| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 767998 | 90411 | BOSUTINIB VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB VIVANTA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 400 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90411/90411_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90411/90411_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | VIVANTA GENERICS S.R.O. SUCURSAL EN ESPANA | 2025-06-26 | 1 | 1 | 1 | 2025-06-27 | 2025-06-26 | 0 | 2025-08-27 | View Edit Delete | ||||||||||||
| 767999 | 90409 | BOSUTINIB VIVANTA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | BOSUTINIB VIVANTA 500 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 500 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90409/90409_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90409/90409_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27271 | VIVANTA GENERICS S.R.O. SUCURSAL EN ESPANA | 2025-06-26 | 1 | 1 | 1 | 2025-06-27 | 2025-06-26 | 0 | 2025-08-27 | View Edit Delete | ||||||||||||
| 767472 | 1201430022 | RYBELSUS 4 MG COMPRIMIDOS | RYBELSUS 4 MG COMPRIMIDOS, 30 comprimidos | 4 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201430022/1201430022_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201430022/1201430022_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2025-04-10 | 1 | 1 | 1 | 2025-04-11 | 2025-04-10 | 0 | 2026-01-13 | View Edit Delete | ||||||||||||
| 767473 | 1201430027 | RYBELSUS 9 MG COMPRIMIDOS | RYBELSUS 9 MG COMPRIMIDOS, 30 comprimidos | 9 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201430027/1201430027_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201430027/1201430027_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2025-04-10 | 1 | 1 | 1 | 2025-04-11 | 2025-04-10 | 0 | 2026-01-13 | View Edit Delete | ||||||||||||
| 767474 | 1201430017 | RYBELSUS 1,5 MG COMPRIMIDOS | RYBELSUS 1,5 MG COMPRIMIDOS, 30 comprimidos | 1,5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/1201430017/1201430017_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1201430017/1201430017_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1974 | NOVO NORDISK PHARMA S.A. | 2025-04-10 | 1 | 1 | 1 | 2025-04-11 | 2025-04-10 | 0 | 2026-01-13 | View Edit Delete | ||||||||||||
| 768407 | 520601IP | VAPORUB POMADA | VAPORUB POMADA, 1 frasco de 100 g | N/A (más de 4 PA) | 6 | 100 | 21 | 1 frasco de 100 g | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/520601IP/520601IP_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 71157 | ELAM PHARMA LABS S.L. | 2025-09-03 | 1 | 1 | 1 | 2025-09-04 | 2025-09-03 | 0 | 2026-02-25 | View Edit Delete | ||||||||||||
| 767913 | 64837 | SOMATULINA AUTOGEL 60 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA | SOMATULINA AUTOGEL 60 mg SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,3 ml | 60 mg | 33 | 1 | 61 | 1 jeringa precargada de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64837/64837_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64837/64837_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 68629 | IPSEN PHARMA S.A.U. | 2002-06-13 | 1 | 1 | 1 | 2002-06-13 | 2002-06-13 | 0 | 2011-10-25 | View Edit Delete | ||||||||||||
| 767970 | 64838 | SOMATULINA AUTOGEL 90 mg, SOLUCION INYECTABLE EN JERINGA PRECARGADA | SOMATULINA AUTOGEL 90 mg, SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,3 ml | 90 mg | 33 | 1 | 61 | 1 jeringa precargada de 0,3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64838/64838_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64838/64838_p.pdf | 1 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 68629 | IPSEN PHARMA S.A.U. | 2002-06-13 | 1 | 1 | 1 | 2002-06-13 | 2002-06-13 | 0 | 2011-10-25 | View Edit Delete | ||||||||||||
| 768370 | 1251964002 | MYNZEPLI 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA | MYNZEPLI 40 MG/ML SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada de 0,09 ml | 3,6 mg inyectable 90 microlitros | 33 | 1 | 61 | 1 jeringa precargada de 0,09 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251964002/1251964002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251964002/1251964002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41367 | ADVANZ PHARMA SPAIN S.L.U. | 2025-08-28 | 1 | 1 | 1 | 2025-08-29 | 2025-08-28 | 0 | 2026-04-13 | View Edit Delete | ||||||||||||
| 767290 | 90227 | CLOTIC 10 MG/ML GOTAS OTICAS EN SOLUCION EN ENVASE UNIDOSIS | CLOTIC 10 MG/ML GOTAS OTICAS EN SOLUCION EN ENVASE UNIDOSIS, 30 envases unidosis de 0,2 ml | 10 mg/ml | 37 | 30 | 51 | 30 envases unidosis de 0,2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90227/90227_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90227/90227_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2513 | LABORATORIOS SALVAT S.A. | 2025-03-20 | 1 | 1 | 1 | 2025-03-21 | 2025-03-20 | 0 | 2025-08-04 | View Edit Delete | ||||||||||||
| 768003 | 82250 | CYCLOGEST 400 MG OVULOS | CYCLOGEST 400 MG OVULOS, 45 óvulos | 400 mg | 42 | 45 | 27 | 45 óvulos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/82250/82250_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/82250/82250_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8334 | GEDEON RICHTER IBERICA S.A. | 2017-07-11 | 1 | 1 | 1 | 2017-07-13 | 2025-06-26 | 0 | 2026-02-24 | View Edit Delete | ||||||||||||
| 767111 | 59531 | BACTROBAN NASAL 20 mg/g POMADA NASAL | BACTROBAN NASAL 20 mg/g POMADA NASAL , 1 tubo de 3 g | 20 mg/g | 44 | 3 | 21 | 1 tubo de 3 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59531/59531_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59531/59531_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3732 | GLAXOSMITHKLINE S.A. | 1992-12-01 | 1 | 1 | 1 | 1992-12-01 | 1992-12-01 | 0 | 2012-01-02 | View Edit Delete | ||||||||||||
| 767711 | 86458 | MUPIROCINA GALENICUMDERMA 20 MG/G POMADA | MUPIROCINA GALENICUMDERMA 20 MG/G POMADA, 1 tubo de 30 g | 20 mg/g | 44 | 30 | 21 | 1 tubo de 30 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86458/86458_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86458/86458_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 67780 | GALENICUM DERMA S.L.U. | 2021-12-21 | 1 | 1 | 1 | 2021-12-22 | 2025-05-13 | 0 | 2025-11-11 | View Edit Delete | ||||||||||||
| 768512 | 90567 | PACLITAXEL ALBUMINA DR REDDYS 5 MG/ML POLVO PARA DISPERSION PARA PERFUSION EFG | PACLITAXEL ALBUMINA DR REDDYS 5 MG/ML POLVO PARA DISPERSION PARA PERFUSION EFG, 1 vial de 50 ml | 100 mg | 45 | 1 | 34 | 1 vial de 50 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90567/90567_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90567/90567_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27152 | REDDY PHARMA IBERIA S.A. | 2025-09-18 | 1 | 1 | 1 | 2025-09-19 | 2025-09-18 | 0 | 2025-11-15 | View Edit Delete | ||||||||||||
| 767971 | 90401 | CEFTAROLINA FOSAMILO QILU 600 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG | CEFTAROLINA FOSAMILO QILU 600 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION EFG, 10 viales | 600 mg | 45 | 10 | 34 | 10 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90401/90401_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90401/90401_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 17309 | SUN PHARMA LABORATORIOS S.L. | 2025-06-19 | 1 | 1 | 1 | 2025-06-20 | 2025-06-19 | 0 | 2025-12-19 | View Edit Delete | ||||||||||||
| 768369 | 1251964001 | MYNZEPLI 40 MG/ML SOLUCION INYECTABLE EN VIAL | MYNZEPLI 40 MG/ML SOLUCION INYECTABLE EN VIAL, 1 vial de 0,1 ml | 4 mg inyectable 100 microlitros | 45 | 1 | 34 | 1 vial de 0,1 ml | 0 | 0 | 1 | 1 | https://cima.aemps.es/cima/pdfs/es/ft/1251964001/1251964001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/1251964001/1251964001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41367 | ADVANZ PHARMA SPAIN S.L.U. | 2025-08-28 | 1 | 1 | 1 | 2025-08-29 | 2025-08-28 | 0 | 2026-04-14 | View Edit Delete | ||||||||||||
| 767135 | 90201 | CICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | CICLOFOSFAMIDA SEACROSS 1.000 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 1.000 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90201/90201_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90201/90201_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | PHARMAVIC IBERICA S.L. | 2025-03-13 | 1 | 1 | 1 | 2025-03-14 | 2025-03-13 | 0 | 2025-09-23 | View Edit Delete | ||||||||||||
| 767136 | 90200 | CICLOFOSFAMIDA SEACROSS 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG | CICLOFOSFAMIDA SEACROSS 500 MG POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFG, 1 vial | 500 mg | 45 | 1 | 34 | 1 vial | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/90200/90200_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/90200/90200_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 41980 | PHARMAVIC IBERICA S.L. | 2025-03-13 | 1 | 1 | 1 | 2025-03-14 | 2025-03-13 | 0 | 2025-09-23 | View Edit Delete | ||||||||||||
| 768050 | 22051 | VAPORUB POMADA | VAPORUB POMADA, 1 envase multidosis de 35 g | N/A (más de 4 PA) | 65 | 35 | 21 | 1 envase multidosis de 35 g | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/22051/22051_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/22051/22051_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8994 | PROCTER & GAMBLE ESPANA S.A. | 1954-12-01 | 1 | 1 | 1 | 1954-12-01 | 2025-07-04 | 0 | 2026-05-11 | View Edit Delete | ||||||||||||
| 769503 | 6816281CIP | CLOPIXOL DEPOT 200 MG/ML SOLUCION INYECTABLE | CLOPIXOL DEPOT 200 MG/ML SOLUCION INYECTABLE, 1 ampolla de 1 ml | 200 mg inyectable 1 ml | 1 | 1 | 1 | 1 ampolla de 1 ml | 0 | 0 | 1 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/6816281CIP/6816281CIP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1250 | DIFARMED S.L.U. | 2025-12-12 | 1 | 1 | 1 | 2025-12-13 | 2025-12-12 | 0 | 2026-03-06 | View Edit Delete |
Page 173 of 1035, showing 20 records out of 20697 total, starting on record 3441, ending on 3460